Antibiotic resistance and antimicrobial resistance (AMR) are among the most critical public health issues facing the NHS in 2026. The World Health Organization lists AMR as one of the top global public health threats, and it is a recurring NHS hot topic in UK medical school interviews.
Antibiotic resistance refers specifically to bacteria becoming resistant to antibiotics. Antimicrobial resistance (AMR) is the broader umbrella term, covering resistance across bacteria, viruses, fungi and parasites. The two phrases are often used interchangeably in interviews, but knowing the distinction shows examiners you understand the science.
For medical school applicants, understanding this topic is crucial not only for your UK medical school interviews but for any career in the healthcare sector.
In this article, we’ll explore antibiotic resistance, why it’s a problem, how it’s being addressed and how it might come up in your medical school interviews as an NHS hot topic.
Antibiotic Resistance Explained: What You Need to Know in 2026
Antibiotic Resistance Statistics (UK and Global, 2026)
A few up-to-date figures will strengthen any interview answer, as long as you quote them honestly. According to UKHSA's ESPAUR surveillance report covering 2024, there were around 20,484 antibiotic-resistant bloodstream infections in England, roughly 400 every week and a 9.3% rise on 2023, with an estimated 2,379 associated deaths. About 65% of these resistant bloodstream infections were caused by E. coli, a common cause of urinary tract infections.
Globally, the most robust recent estimate comes from the GRAM study published in The Lancet in 2024: around 1.14 million deaths were directly attributable to bacterial AMR in 2021, with a further 4.71 million deaths associated with it. The same study forecasts roughly 1.9 million directly attributable deaths a year by 2050 and around 39 million cumulative deaths between 2025 and 2050.
You may also hear the widely quoted figure of 10 million deaths a year by 2050 from the 2016 O'Neill Review. Use it carefully: it is a modelled, worst-case projection that has been criticised for not publishing confidence intervals and for not being peer reviewed. Showing that you can distinguish a measured estimate (GRAM) from a contested forecast (O'Neill) is exactly the kind of nuance interviewers reward.
Antibiotic resistance is an important topic to cover during your preparation for your UK medical school interviews. Here is a summary of what you need to know about antibiotic resistance.
Antibiotic resistance occurs when bacteria evolve to evade antibiotics, making infections harder to treat.
It’s fueled by overuse and misuse of antibiotics in medicine and agriculture.
Superbugs like MRSA are resistant to multiple antibiotics, limiting treatment options.
Prevention involves using antibiotics responsibly, completing prescriptions, and maintaining good hygiene.
Global and UK actions include reducing misuse, funding the development of new treatments, and ensuring equitable access to antibiotics. In the UK, the government's 5-year National Action Plan, “Confronting antimicrobial resistance 2024 to 2029” (published May 2024), commits to cutting total human antibiotic use by 5% and raising public and professional knowledge of AMR by 10% by 2029.
Antimicrobial Resistance (AMR) - What Is It and Why Is It Important for Aspiring Medical Students?
Antibiotic resistance describes a state where bacteria are immune to a particular antibiotic.
It occurs when bacteria evolve and develop the ability to survive exposure to antibiotics to which they were previously sensitive.
Antibiotic resistance is accelerated by the overuse and incorrect use of antibiotics. The greater the exposure of a bacteria to antibiotics, the increased likelihood of antibiotic resistance developing, and antibiotics becoming ineffective.
Resistant bacteria can spread between people, leading to outbreaks of difficult-to-treat bacterial infections. An example of antibiotic-resistant bacteria includes Methicillin-resistant Staphylococcus aureus, also known as MRSA, which can cause severe illness and infections in humans.
What Causes Antibiotic Resistance? Causes and Drivers
Antibiotic resistance is caused by genetic mutations and selection pressures leading to the survival and expansion of bacteria which are resistant to antibiotics.
Genetic Mutations: Bacteria naturally gain genetic mutations, and some mutations may confer resistance to an antibiotic.
Selective Pressure: The use of antibiotics creates a selection pressure, causing sensitive bacteria to be killed, but allowing the resistant bacteria to survive. Resistant bacteria are then able to reproduce and increase in population size.
Spread Of Resistance: Increased exposure to antibiotics causes resistance to increase, these resistance genes can spread between different bacteria and cause drug resistance.
How Antibiotic Resistance Impacts NHS Healthcare: A Guide for Medical School Applicants
Antibiotic resistance is one of the most pressing challenges facing the NHS today. As bacteria evolve and develop resistance to existing antibiotics, the effectiveness of routine treatments diminishes.
The latest UKHSA surveillance underlines the scale of the problem: resistant bloodstream infections in England rose to around 20,484 in 2024 (up 9.3% on the previous year), the equivalent of nearly 400 new cases every week, with about 2,379 associated deaths. These are real, measured NHS figures you can cite with confidence.
This growing threat poses significant risks to patient safety and the overall functioning of the NHS.
Here are some of the major ways antibiotic resistance impacts the NHS:
Compromised Routine Procedures: In the NHS, procedures like surgeries, organ transplants, and chemotherapy rely heavily on antibiotics to prevent post-operative infections. As resistance increases, the ability to safely carry out these procedures diminishes, putting patients at greater risk of developing infections that are harder to treat. This directly impacts recovery times and increases the likelihood of complications.
Increased Hospital Admissions and Longer Stays: Patients suffering from antibiotic-resistant infections often require prolonged hospital stays, leading to greater pressure on NHS resources. These infections are more challenging and costly to treat, requiring second or third-line antibiotics, which may be less effective and come with more severe side effects. This strains the healthcare system, contributing to bed shortages and delays in patient care.
Higher Mortality Rates: Antibiotic-resistant infections, such as those caused by Methicillin-resistant Staphylococcus aureus (MRSA), have significantly higher mortality rates. As these infections become more common, the NHS faces the challenge of not only managing a rising number of deaths but also addressing the public health concerns associated with the spread of superbugs in hospital settings.
Escalating Healthcare Costs: Treating antibiotic-resistant infections is considerably more expensive than treating infections susceptible to first-line antibiotics. The need for more intensive care, specialised treatments, and longer hospital stays contributes to escalating costs for the NHS. This also diverts funds from other areas of healthcare, limiting the ability of the NHS to invest in preventive care and other essential services.
Delayed Diagnosis and Treatment: As doctors are forced to rely on more complex diagnostic methods to identify antibiotic-resistant strains, the delay in initiating the appropriate treatment can lead to worse outcomes. The need for precise identification of resistant bacteria can slow down the healthcare process, resulting in longer waiting times and more complicated cases of illness.
For medical school applicants like yourself, understanding how antibiotic resistance impacts the NHS is critical. It is not just a clinical issue; it affects healthcare policy, resource allocation, and patient safety.
How Can We Reduce Antimicrobial Resistance? NHS Solutions
The UK National Action Plan and the One Health Approach
The UK's response to AMR is set out in its 5-year National Action Plan, “Confronting antimicrobial resistance 2024 to 2029”, published in May 2024. It builds on the previous 2019-2024 plan and sets concrete targets for 2029, including reducing total antibiotic use in humans by 5% and increasing public and healthcare-professional knowledge of AMR by 10%. Naming this plan in an interview signals genuine, current awareness of NHS policy.
A central idea is “One Health”: the recognition that human health, animal health, food production and the environment are interconnected, so AMR cannot be solved in hospitals alone. The plan therefore coordinates action across the NHS, veterinary medicine, agriculture and water systems, and the UK continues to advocate for similar cooperation internationally following the 2024 UN High-Level Meeting on AMR.
Where AMR meets everyday NHS care, schemes like the NHS Pharmacy First Initiative matter. By letting community pharmacists manage seven common conditions, Pharmacy First aims to ease GP pressure, but it also has to be delivered with strong stewardship so that easier access does not lead to more unnecessary antibiotic prescriptions. A thoughtful candidate can link the two and discuss the trade-off.
Reducing antibiotic resistance requires the collaboration of healthcare professionals, patients, and global initiatives.
Methods currently being used to reduce antibiotic resistance include:
Responsible Antibiotic Use: Only use antibiotics when appropriately prescribed by a healthcare professional, and avoid taking them for viral infections like colds or the flu. The full course of antibiotics must be taken, even if symptoms have fully improved, to ensure all bacteria are eliminated.
Antibiotic Stewardship Programmes: Healthcare providers should implement antibiotic stewardship programs to monitor and regulate the use of antibiotics in hospitals and clinics. These programs promote the most effective use of antibiotics and unnecessary prescriptions.
Infection Prevention: Reducing the spread of infections can decrease the need for antibiotics. This can be achieved in the community through the promotion of hygiene programmes, and in the hospital through proper hand-washing, vaccinations, and infection control.
Public Education: Raising awareness about the dangers of antibiotic misuse and the importance of infection prevention can help reduce unnecessary antibiotic use in the community.
The Broken Antibiotic Pipeline and the “Netflix” Subscription Model
One reason AMR is so hard to tackle is market failure: developing a new antibiotic is expensive, yet any new drug is deliberately held in reserve to slow resistance, so it sells in very low volumes. That makes antibiotics commercially unattractive, and many large companies have left the field, leaving a thin development pipeline. This is a strong, less obvious point to raise in an interview.
To fix this, England launched the world's first “Netflix-style” subscription model for antibiotics. Instead of paying per pack, the NHS pays drug companies a fixed annual fee (in bands of roughly £5 million to £20 million) for access to a valuable new antibiotic, with NICE assessing its worth. The first two drugs were contracted in 2024, and an expanded scheme covering more antibiotics across the UK began in April 2026. It “de-links” company income from sales volume, rewarding the value of having an antibiotic available rather than how much is used, which supports stewardship at the same time.
The rise of antibiotic resistance presents significant ethical challenges, particularly in healthcare and global public health. Here are key ethical considerations:
Equitable Access to Treatment:
As antibiotic resistance grows, the development of new treatments may be costly and limited in availability.
The ethical principle of justice denotes that life-saving antibiotics and treatments should be accessible to all, particularly in low-income countries, where resistance is rising but healthcare resources are limited.
Overuse and Misuse of Antibiotics:
The overprescription of antibiotics, both in healthcare and agriculture, raises ethical concerns.
Doctors face the dilemma of balancing patient needs against the long-term public health impact of increasing antibiotic resistance.
Ethical stewardship involves prescribing antibiotics only when truly necessary, to protect both current and future patients.
Global Responsibility:
Antibiotic resistance is a global issue.
Wealthier countries often have more resources to combat resistance, while developing countries may struggle.
There is a moral responsibility for international cooperation in funding research, sharing data, and ensuring that antibiotic resistance solutions are distributed globally.
Animal Agriculture and Public Health:
The use of antibiotics in animal farming for growth promotion and disease prevention contributes to resistance.
There is an ethical debate about balancing the economic benefits of this practice with the risk to public health.
Reducing antibiotic use in agriculture can help reduce resistance, but it requires dismantling industry practices.
How To Answer Medical School Interview Questions On Antibiotic Resistance
Medical school interviews often test your understanding of complex topics like antibiotic resistance. Here's a step-by-step guide on how to craft a strong answer:
Show a Solid Understanding of the Science Behind Antibiotic Resistance
You should be able to define antibiotic resistance clearly and concisely.
For example:
“Antibiotic resistance occurs when bacteria evolve to survive exposure to antibiotics, making treatments less effective and infections harder to manage.”
You should be able to describe the key drivers of antibiotic resistance, such as overuse in healthcare and agriculture, and how bacteria develop resistance through genetic mutations.
Ultimate Package
Choose your Ultimate Package
Rated 5.0 from 550+ reviews. 1-1 mentoring from doctors across UCAT, personal statement and interviews.
In your answer, you should highlight how antibiotic resistance is a major public health threat.
For example:
“As resistance grows, routine infections become more difficult to treat, leading to longer hospital stays, increased healthcare costs, and higher mortality rates.”
In your answer, you should include the wider impacts of antibiotic resistance, such as medical procedures like surgeries or cancer treatments being delayed
Emphasise the Role of Healthcare Professionals
You should comment on the responsibility of future doctors in preventing antibiotic resistance.
For example:
“As doctors, it’s essential to prescribe antibiotics only when necessary and educate patients on proper use. Implementing antibiotic stewardship programs in hospitals can help reduce misuse.”
Acknowledge Global and Ethical Dimensions
When describing antibiotic resistance, you must demonstrate that you understand the global scope of the issue, including the ethical responsibilities to ensure equitable access to effective treatments.
For example:
“Antibiotic resistance is a global issue which disproportionately affects low-income countries. We must collaborate globally to ensure new antibiotics and treatments are accessible to all.”
Offer Solutions and Forward-Thinking Ideas
When discussing solutions to antibiotic resistance, you should highlight that it is not a simple issue, and must be approached from many different angles, such as investing in research for new antibiotics, improving infection prevention, and educating the public on the responsible use of antibiotics.
Antibiotic Resistance Medicine Interview Questions and Model Answers
What Is Antibiotic Resistance, And Why Is It A Concern In Modern Medicine?
Antibiotic resistance happens when bacteria evolve to survive antibiotics that are meant to kill them or stop their growth. This is becoming a major concern in modern medicine because it makes infections that were once easy to treat much harder to manage.
As a result, patients may suffer longer illnesses, higher healthcare costs, and in some cases, the risk of death increases. I saw this during my work experience on a hospital ward where patients with antibiotic-resistant infections required longer stays and more complex treatments.
It’s not just about infections either. Antibiotic resistance threatens the success of routine procedures like surgeries and cancer treatments, where antibiotics are vital for preventing and treating infections. The overuse and misuse of antibiotics in both healthcare and agriculture contribute to this growing problem, making it a critical issue for public health worldwide.
What Can Doctors Do To Prevent The Spread Of Antibiotic Resistance?
As future doctors, I think we have a vital role in preventing the spread of antibiotic resistance. One of the key things we can do is make sure we only prescribe antibiotics when absolutely necessary, selecting the right type and dose.
I saw this in action during my work experience in a GP surgery, where the doctor carefully explained to a patient why antibiotics weren’t needed for their viral infection. It struck me how important patient education is in this process—helping people understand that antibiotics aren’t always the solution.
In addition to responsible prescribing, we need to be part of antibiotic stewardship programmes within hospitals, which monitor how antibiotics are used and promote best practices. I also saw how simple infection prevention measures, like promoting vaccinations and hand hygiene, help reduce the need for antibiotics in the first place. It’s about combining responsible prescribing with broader efforts to reduce infections, which can help slow the spread of resistance.
Antibiotic Resistance Practice Interview Questions
Here are 10 antibiotic resistance practice interview questions. Have a go with friends or family, and test how you would answer the following:
What is antibiotic resistance, and why is it a growing concern in healthcare?
Can you simply explain how bacteria develop antibiotic resistance, and what factors accelerate this process?
What are the consequences of antibiotic resistance for medical procedures like surgeries?
How can healthcare professionals help reduce the spread of antibiotic resistance?
What are some global strategies being implemented to combat antibiotic resistance?
Why is it important to regulate the use of antibiotics in agriculture, and how does it impact human health?
What are the ethical challenges of prescribing antibiotics, especially when patients expect them for viral infections?
How would you deal with a patient who is demanding antibiotics for a viral infection?
How can we incentivise pharmaceutical companies to invest in the development of new antibiotics?
What is the UK doing about antimicrobial resistance, and is the 2024-2029 National Action Plan likely to work?
Should easier access to antibiotics through schemes like Pharmacy First worry us, and how do we balance access with stewardship?
FAQs
Frequently asked questions
What is antibiotic resistance, in simple terms?
Antibiotic resistance is when bacteria evolve so that the antibiotics designed to kill them no longer work. It happens through random genetic mutations and the spread of resistance genes, and is accelerated when antibiotics are overused or misused. The result is that once-routine infections become harder, slower and more expensive to treat, and in some cases untreatable.
What is the difference between antibiotic resistance and antimicrobial resistance (AMR)?
Antibiotic resistance refers specifically to bacteria becoming resistant to antibiotics. Antimicrobial resistance (AMR) is the broader umbrella term, covering resistance across bacteria, viruses, fungi and parasites. So all antibiotic resistance is antimicrobial resistance, but AMR also includes things like antifungal and antiviral resistance. Interviewers often check whether you know this distinction.
What is the meaning of AMR in medicine?
AMR stands for antimicrobial resistance. In medicine it means microbes (bacteria, viruses, fungi or parasites) have changed so that the medicines used to treat the infections they cause stop working. The WHO lists AMR among the top global public health threats, because it undermines treatment of common infections and the safety of surgery, chemotherapy and transplants.
What causes antibiotic resistance?
Antibiotic resistance is driven by genetic mutation and selective pressure. When antibiotics are used, susceptible bacteria die while naturally resistant ones survive, reproduce and pass on resistance genes, which can also jump between bacteria. Overuse and misuse, such as taking antibiotics for viral infections or not finishing a course, plus heavy use in farming, all speed the process up.
How does antibiotic resistance affect the NHS?
Antibiotic resistance makes infections harder to treat, lengthening hospital stays, raising costs and increasing deaths. It threatens routine procedures such as surgery, chemotherapy and transplants, which rely on antibiotics to prevent infection. UKHSA data for 2024 recorded around 20,484 resistant bloodstream infections in England (about 400 a week) and roughly 2,379 associated deaths, adding real pressure to an already stretched NHS.
What are the latest UK antibiotic resistance statistics?
According to UKHSA's ESPAUR report covering 2024, there were about 20,484 antibiotic-resistant bloodstream infections in England, a 9.3% rise on 2023 and the equivalent of nearly 400 new cases every week, with an estimated 2,379 associated deaths. Around 65% of these resistant bloodstream infections were caused by E. coli, a frequent cause of urinary tract infections.
How many people die from AMR globally each year?
The GRAM study in The Lancet (2024) estimated about 1.14 million deaths were directly attributable to bacterial AMR worldwide in 2021, with around 4.71 million more deaths associated with it. It forecasts roughly 1.9 million directly attributable deaths a year by 2050. The older, widely quoted O'Neill figure of 10 million a year by 2050 is a contested, worst-case projection.
What is the UK doing about antimicrobial resistance in 2026?
The UK is delivering its 5-year National Action Plan, “Confronting antimicrobial resistance 2024 to 2029” (published May 2024). It targets a 5% cut in human antibiotic use and a 10% rise in public and professional knowledge by 2029, uses a “One Health” approach across human and animal health and the environment, and funds new antibiotics through a world-first subscription payment model.
What is the “Netflix” subscription model for antibiotics?
It is a world-first NHS scheme where drug companies are paid a fixed annual fee (in bands of roughly £5-20 million) for access to a valuable new antibiotic, rather than being paid per pack. NICE assesses each drug's value. This “de-links” income from sales volume, encouraging companies to develop antibiotics that must be used sparingly. An expanded UK-wide version began in April 2026.
What is antimicrobial stewardship?
Antimicrobial stewardship is the coordinated effort to use antibiotics responsibly: prescribing them only when necessary, choosing the right drug, dose and duration, and reviewing treatment as results come in. In hospitals and GP surgeries, stewardship programmes monitor prescribing, audit practice and educate staff and patients, all to preserve antibiotic effectiveness and slow the development of resistance.
What are superbugs, and why are they dangerous?
Superbugs are bacteria resistant to multiple antibiotics, leaving very few treatment options. Examples include MRSA (methicillin-resistant Staphylococcus aureus) and some resistant E. coli and Klebsiella strains. They are dangerous in healthcare settings because patients are often already unwell or immunocompromised, so infections spread easily, are hard to treat and carry higher mortality, while also driving up hospital costs and length of stay.
How does antibiotic use in farming contribute to resistance?
Using antibiotics in livestock for disease prevention or growth promotion exposes large numbers of bacteria to drugs, selecting for resistant strains. These can reach humans through food, water or direct contact. This is why the UK's “One Health” approach tackles AMR across agriculture, the environment and human medicine together, and why reducing farm antibiotic use is part of the national strategy.
Are there alternatives to antibiotics?
Researchers are exploring alternatives such as bacteriophages (viruses that target bacteria), antimicrobial peptides, monoclonal antibodies, microbiome therapies and, crucially, vaccines that prevent infections so antibiotics are needed less often. Most non-vaccine options remain largely experimental and are not yet routine in NHS care, so prevention, stewardship and developing new antibiotics still do most of the heavy lifting.
How would you answer an antibiotic resistance question in a medicine interview?
Define it clearly, explain the causes (mutation, selective pressure, overuse in healthcare and farming), then discuss the impact on the NHS and globally. Quote a current, honest statistic, name the UK 2024-2029 National Action Plan, and offer balanced solutions: stewardship, infection control, vaccination and new-drug funding. Showing you can weigh patient demand against long-term public health demonstrates strong ethical reasoning.
How should a doctor respond to a patient demanding antibiotics for a viral infection?
Listen to the patient's concerns, then explain clearly and kindly that antibiotics do not work on viruses and may cause side effects and resistance. Offer a safe alternative plan: symptom relief, safety-netting on when to seek further help, and sometimes a delayed prescription. This balances respect for patient autonomy with the doctor's duty of stewardship, protecting both this patient and future ones.
How does Pharmacy First relate to antibiotic resistance?
The NHS Pharmacy First Initiative lets community pharmacists treat seven common conditions, easing GP pressure and improving access. The link to AMR is a trade-off: faster, easier access must be paired with strong stewardship so it does not lead to more unnecessary antibiotic prescriptions. Discussing this balance shows interviewers you can connect NHS policies rather than treat them in isolation.
Ultimate Package students from our 2025/26 cycle, with their UCAT scores and offers, who trained with us for the UCAT, personal statements and interviews.
Ultimate Package
S
Sophie
Medicine, King's College London
2025 UCAT2,590 / 2,700
“Harry got my UCAT up to 2,590, working through the sections I kept dropping marks on week by week. Gemma then ran my interview practice so the MMI stations didn't catch me out, and Dr Akash mentored me the whole way through. I'm off to King's for Medicine.”
Ultimate Package
D
Daniel
Medicine, University College London
Medicine offers4 offers
“The interview prep was the part that actually moved the needle. Proper mock MMIs, not just lists of questions, and feedback that was honest about what I was getting wrong. I ended up with four offers and firmed UCL.”
Ultimate Package
A
Aisha
Dentistry, University of Birmingham
Dentistry offers4 offers
“The Ultimate Package kept me organised from UCAT through to interviews. They knew what dental schools actually ask and tightened up my personal statement. Four offers in the end, and I'm going to Birmingham.”
Ultimate Package
C
Charlotte
Veterinary Medicine, Royal Veterinary College
Vet offers4 offers
“Vet applications come down to the written SAQs as much as the interview. Dr Rebecca went through my SAQs line by line, sharpened my answers and prepped me for the panels. I came away with four offers and chose the RVC.”
